ResMed Inc. (ASX:RMD) Reports Q1 2025 Financial Results
ResMed Inc. (ASX:RMD) reports Q1 2025 revenues up 8% and diluted EPS of $2.48, declaring a $0.53 dividend per share.
Category: ASX-RMD
ResMed Inc.
Latest News
Radiopharm Theranostics (ASX:RAD) Begins Phase 2b U.S. Trial for 18F-RAD101
Unibail-Rodamco-Westfield (ASX:URW) Announces Q1 2025 Trading Update
Sayona Mining Limited (ASX:SYA) Reports High-Grade Lithium Drill Results
Hansen Technologies Ltd (ASX:HSN) Acquires Strategic Assets in Germany
Coventry Group Ltd (ASX:CYG) Announces Q3 FY25 Trading Update
NOVONIX (ASX:NVX) Appoints Michael O’Kronley as CEO
Orthocell Limited (ASX:OCC) Gains Thai FDA Approval for Remplir™
Lynas Rare Earths Ltd (ASX:LYC) Announces Q3 FY25 Quarterly Report
ResMed Inc. (ASX:RMD) Reports Q1 2025 Financial Results
Eagle Mountain Mining (ASX:EM2) Completes Rights Issue
The Hub of Australian Finance News